Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study

OBJECTIVE: To examine the association between plasma levels of the soluble urokinase plasminogen activator receptor (suPAR) and the incidence of severe complications of COVID-19. METHODS: 403 RT-PCR-confirmed COVID-19 patients were recruited and prospectively followed-up at a major hospital in the U...

Descripción completa

Detalles Bibliográficos
Autores principales: Oulhaj, Abderrahim, Alsuwaidi, Ahmed R., Suliman, Abubaker, Gasmelseed, Huda, Khan, Shaima, Alawi, Shamma, Hukan, Yaman, George, Junu, Alshamsi, Fayez, Sheikh, Farrukh, Babiker, Zahir Osman Eltahir, Prattes, Juergen, Sourij, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056823/
https://www.ncbi.nlm.nih.gov/pubmed/33862208
http://dx.doi.org/10.1016/j.ijid.2021.04.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056823/
https://www.ncbi.nlm.nih.gov/pubmed/33862208
http://dx.doi.org/10.1016/j.ijid.2021.04.026

Ejemplares similares